Section Arrow
PMVP.NASDAQ
- PMV Pharmaceuticals
Quotes are at least 15-min delayed:2025/06/04 12:41 EDT
Last
 0.9212
+0.0019 (+0.21%)
Day High 
0.9296 
Prev. Close
0.9193 
1-M High
Volume 
46.04K 
Bid
0.92
Ask
0.9274
Day Low
0.905 
Open
0.905 
1-M Low
0.81 
Market Cap 
47.76M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.9 
20-SMA 0.88 
50-SMA 0.97 
52-W High 1.83 
52-W Low 0.81 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.18/-1.94
Enterprise Value
48.60M
Balance Sheet
Book Value Per Share
3.08
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CLRBCellectar Biosciences0.4367+0.1591+57.31%-- 
NCNANuCana plc0.0459-0.0139-23.24%-- 
RXRXRecursion Pharmaceuticals4.955+0.565+12.87%-- 
SGMTSagimet Biosciences4.3312+0.7012+19.32%-- 
BPMCBlueprint Medicines Corp128.04+0.44+0.34%-- 
Quotes are at least 15-min delayed:2025/06/04 12:41 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.